LCA168 FOR GLIOBLASTOMA?

Glioblastoma is a dangerous brain tumor known for its rapid growth and insensitivity to conventional treatments. Research are constantly underway to identify new management strategies, and recently, a new biomarker named LCA168 has emerged as a potential target for glioblastoma treatment. LCA168 is a protein that is abundantly produced in GBM cell